[Clinical effectiveness and immunological control of the immunochemotherapy of acute leukemia in children using a Corynebacterium parvum preparation].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003165:Complement System Proteins / Q000032:analysis; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000628:therapy*; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011425:Propionibacterium acnes; D013997:Time Factors
D000276:Adjuvants, Immunologic; D001798:Blood Proteins; D007136:Immunoglobulins; D003520:Cyclophosphamide; D003165:Complement System Proteins; D015122:Mercaptopurine; D008727:Methotrexate
Klinicheskaia éffektivnost' i immunologicheskiĭ kontrol' khimioimmunoterapii ostrogo leĭkoza u deteĭ preparatom "Korinebakterium parvum".